Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial.
Dimitrios ChanouzasLovesh DyallPeter NightingaleCharles FerroPaul MossMatthew David MorganLorraine HarperPublished in: Trials (2016)
ClinicalTrials.gov Identifier NCT01633476 (registered 29 June 2012).